风湿病治疗用生物制剂

被引:8
作者
孔宁
吕玲
万伟国
机构
[1] 复旦大学附属华山医院风湿科
关键词
生物制剂; 抗风湿药; 风湿病; 治疗;
D O I
暂无
中图分类号
R593.2 [自身免疫性疾病、结缔组织疾病];
学科分类号
100201 [内科学];
摘要
生物制剂因具有靶向特点,近10年来在风湿病治疗领域中得到了广泛应用。本文介绍目前已获准用于临床的各生物制剂的特点以及这些生物制剂类慢作用抗风湿药在各种风湿病治疗中的应用和不良反应。
引用
收藏
页码:14 / 18
页数:5
相关论文
共 14 条
[1]
Biologics and heart failure in rheumatoid arthritis:are we any wiser?..Danila MI;Nivedita M;Patkar NM;et al;.Curr Opin Rheumatol.2008, 03
[2]
Ocular Beh?et disease: current therapeutic approaches.[J].Cem Evereklioglu.Current Opinion in Ophthalmology.2011, 6
[3]
Efficacy and safety of abatacept in patients with rheumatoid arthritis and no prior treatment with biologics [J].
Contreras, Alejandro Escudero ;
Carmen Castro-Villegas, M. ;
Vanesa Hernandez-Hernandez, M. ;
Diaz-Gonzalez, Federico .
REUMATOLOGIA CLINICA, 2011, 7 (06) :392-396
[4]
Efficacy of rituximab versus cyclophosphamide in lupus patients with severe manifestations. A randomized and multicenter study [J].
Andrade-Ortega, Lilia ;
Irazoque-Palazuelos, Fedra ;
Lopez-Villanueva, Ricardo ;
Barragan-Navarro, Yaneth ;
Bourget-Pietrasanta, Fernando ;
de los Angeles Diaz-Ceballos, Maria ;
Hernandez-Paz, Roberto ;
Urenda-Quezada, Adelfia ;
Rivas-Ruiz, Rodolfo .
REUMATOLOGIA CLINICA, 2010, 6 (05) :250-255
[5]
Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial [J].
Kameda, Hideto ;
Ueki, Yukitaka ;
Saito, Kazuyoshi ;
Nagaoka, Shouhei ;
Hidaka, Toshihiko ;
Atsumi, Tatsuya ;
Tsukano, Michishi ;
Kasama, Tsuyoshi ;
Shiozawa, Shunichi ;
Tanaka, Yoshiya ;
Takeuchi, Tsutomu .
MODERN RHEUMATOLOGY, 2010, 20 (06) :531-538
[6]
Two‐year clinical and radiographic results with combination etanercept–methotrexate therapy versus monotherapy in early rheumatoid arthritis: A two‐year; double‐blind; randomized study.[J].PaulEmery;FerdinandBreedveld;Désiréevan der Heijde;GianfrancoFerraccioli;MaximeDougados;DeborahRobertson;RonaldPedersen;Andrew S.Koenig;BruceFreundlich.Arthritis & Rheumatism.2010, 3
[7]
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview [J].
Singh, Jasvinder A. ;
Christensen, Robin ;
Wells, George A. ;
Suarez-Almazor, Maria E. ;
Buchbinder, Rachelle ;
Lopez-Olivo, Maria Angeles ;
Ghogomu, Elizabeth Tanjong ;
Tugwell, Peter .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 181 (11) :787-796
[8]
Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study [J].
Takeuchi, Tsutomu ;
Miyasaka, Nobuyuki ;
Inoue, Kazuhiko ;
Abe, Tohru ;
Koike, Takao .
MODERN RHEUMATOLOGY, 2009, 19 (05) :478-487
[9]
Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy [J].
Nishimoto, Norihiro ;
Miyasaka, Nobuyuki ;
Yamamoto, Kazuhiko ;
Kawai, Shinichi ;
Takeuchi, Tsutomu ;
Azuma, Junichi ;
Kishimoto, Tadamitsu .
MODERN RHEUMATOLOGY, 2009, 19 (01) :12-19
[10]
Retrospective claims data analysis of dosage adjustment patterns of TNF antagonists among patients with rheumatoid arthritis [J].
Wu, Eric ;
Chen, Lei ;
Birnbaum, Howard ;
Yang, Elaine ;
Cifaldi, Mary .
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (08) :2229-2240